1 Min Read
Dec 20 (Reuters) - Apellis Pharmaceuticals Inc
* Apellis announces fda fast track designation for apl-2 in pnh Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.